A recent report published by Infinium Global Research on the thyroid eye disease treatment market provides an in-depth analysis of segments and
sub-segments in the global as well as regional thyroid eye disease treatment
market. The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional thyroid eye disease treatment market over
the short term as well as long term. The report is a comprehensive presentation
of trends, forecasts, and dollar values of the global thyroid eye disease treatment
market. According to the report, the global thyroid eye disease treatment
market is projected to grow at a healthy CAGR over the forecast period of
2019-2025.
Thyroid eye disease is a condition that causes inflammation
in the eyelids, eye muscles, tear glands, and fatty tissues behind the eye. It
occurs when the body’s immune system attacks the tissues around the eye that
cause inflammation in the tissues. It is also called as Grave’s Orbitopathy or
Ophthalmopathy. It leads to the swallowing of eyes and can cause eyes and eyelids
to become red. The thyroid eye disease also causes reduced vision due to
pressure on the nerve at the back of the eye.
The rising prevalence of thyroid eye disease drives the
growth of the thyroid eye disease treatment market. A study estimated that
around 16 women per 100000 ad 3 men per 100000 have thyroid eye disease.
Thyroid eye prevalence is higher in women than in men. The favorable
reimbursement policies for the treatment of thyroid disorders and increasing
awareness about the complications related to thyroid disorders contribute to
the expansion of the market. Further, thyroid eye disease mostly occurs in
people living with Grave’s disease or hyperthyroidism. A study estimated that
around 60 % of patients with hyperthyroidism will develop thyroid eye disease.
Thus rise in the number of people suffering from Grave’s diseases promotes the
expansion of the thyroid eye disease treatment market. Further, smoking is one
of the reasons contributing to the prevalence of thyroid eye diseases. Smoking
increases the risk of thyroid eye disease by 7-8 times and also minimizes the
effectiveness of treatments. In addition, growing improvement in healthcare
infrastructure and a rising number of ophthalmologists escalate the development
of thyroid eye disease treatment market. On the flip side, side effects
associated with the drugs hinders the growth of thyroid eye disease treatment
market. Moreover, growing research to develop a novel therapy for thyroid eye disease
treatment creates several opportunities for the growth of thyroid eye disease
treatment market.
Geographically, the global thyroid eye disease treatment
market is divided into North America, Asia-Pacific, Europe, and the Rest of the
World. North America is anticipated to hold a dominant share in the global
thyroid eye disease treatment market. The presence of well-established
healthcare infrastructure and the rising prevalence of thyroid eye disease in
North America drive the growth market in the region. Europe is anticipated to
grow in the global thyroid eye disease treatment market with a healthy CAGR
over the forecast period. The growth of the thyroid eye disease treatment
market in Europe is attributed to the availability of superior treatment options
in the region. Asia-Pacific region has lucrative growth opportunities in the
global thyroid eye disease treatment market. The improving healthcare
infrastructure in Asia-Pacific led to the expansion of the thyroid eye disease
treatment market in the region.
The report on global thyroid eye disease treatment market
covers segments such as drug type, and distribution channel. On the basis of
drug type, the sub-markets include vitamins, corticosteroids, monoclonal
antibody, and other drug types. On the basis of distribution channel, the
sub-markets include retail pharmacies, hospital pharmacies, and online
pharmacies.
The report provides profiles of the companies in the market
such as Novartis AG, Pharmos Corporation, Hi-Tech Pharmacal Co Inc., Allergan
plc, Pfizer Inc., Horizon Therapeutics plc, Kala Pharmaceuticals Inc., Bausch
And Lomb Inc., Eyevance Pharmaceuticals LLC, Mylan N.V., and Other companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of the thyroid eye
disease treatment market. Moreover, the study highlights current market trends
and provides forecasts from 2019-2025. We also have highlighted future trends in
the market that will affect the demand during the forecast period. Moreover,
the competitive analysis given in each regional market brings an insight into
the market share of the leading players.